Skip to main content
. Author manuscript; available in PMC: 2010 Mar 4.
Published in final edited form as: Vaccine. 2009 Jan 23;27(10):1549–1556. doi: 10.1016/j.vaccine.2009.01.010

Figure 1.

Figure 1

Schematic representation of two vaccine studies in rhesus monkeys utilizing recombinant poxvirus vaccine vectors. rDNA, rVV, rMVA, and rFPV are recombinant vectors expressing SIV Gag and HIV-1 Env vaccine inserts. (A) Monkeys (7 per group) received rDNA prime/recombinant poxvirus or rDNA boost vaccinations as described in Materials and Methods. (B) Monkeys (6 per group) received recombinant poxvirus prime/recombinant poxvirus boost vaccinations. All poxvirus immunizations were administered by intramuscular and intradermal injections with 2×109 pfu.